Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next-Gen MS: A Prospective, Cluster-randomized Study Evaluating the Impact of "Feed-forward" Patient Reported Outcomes Data to Clinical Teams Managing Adults Living With MS in a Learning Health System for MS Research

NCT04907305 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.

NCT NCT04907305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next-Gen MS: A Prospective, Cluster-randomized Study Evaluating the Impact of "Feed-forward" Patient Reported Outcomes Data to Clinical Teams Managing Adults Living With MS in a Learning Health System for MS Research
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Phase
Observational
Overall status
Terminated
Start date
November 2, 2021
Completion date
February 19, 2024
Enrollment
1,594 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms)